Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioMimetic Therapeutics Inc.

Division of Wright Medical Group NV
www.biomimetics.com

Latest From BioMimetic Therapeutics Inc.

Augment Bone Graft Biologic – Fastest-Growing In The Portfolio

Wright's move into breakthrough biologics.

Medical Device

Wright Sees Potential $1B+ Market Opportunity With Newly-Approved Orthobiologic

The Augment biologic-based device was approved for use in ankle and hindfoot fusions after overcoming multiple regulatory challenges, opening up a $300 million US market opportunity. It's the first indication for a product platform that Wright hopes to extend to use in soft-tissue procedures such as rotator cuff or tennis elbow repair, which represent a $1 billion-plus opportunity.

Medical Device Innovation

Wright Brings New Biologic To U.S. Ortho Space With Augment Approval

The Augment biologic-based device was approved for use in ankle and hindfoot fusions after overcoming multiple regulatory challenges.

Medical Device

Vendor Inspections Hold Up Wright's Augment Graft Approval

Wright received an "approvable" letter from FDA about nine months ago for its Augment biologic-device bone graft, but the approval is delayed as the agency performs multiple inspections and has issued two Form-483s to a component supplier for the product.

See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Wound Healing & Tissue Repair
  • Alias(es)
  • BioMimetic Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Wright Medical Group NV
  • Senior Management
  • Samuel E Lynch, Pres. & CEO
    Larry Bullock, CFO
    Leo Snel, SVP, R&D & Protein Chemistry
  • Contact Info
  • BioMimetic Therapeutics Inc.
    Phone: (615) 844-1280
    389 Nichol Mill Ln.
    Franklin, TN 37067
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register